By screening the expression levels of 754 human miRs using miR arrays in 16 breast tumor samples from 8 cases with local recurrence and 8 cases without local recurrence, Zhou and his colleagues reported that microRNA-9 could be used as a potential biomarker for breast cancer local recurrence and tumor estrogen receptor status [33]. This evidence concerns the gene ESR1 and breast neoplasm.